Wolfe upgrades Bruker to Outperform on 2026 growth

Wolfe Research upgraded Bruker (BRKR) to Outperform from Peer Perform with a $60 price target The firm cites its 2026 outlook for the upgrade, which assumes low-single-digit revenue growth, 200 basis points of margin expansion, and low- to mid-teens earnings growth for Bruker. The company’s semiconductor orders shifted into the first half of 2026 from the second half of 2025, which brings good visibility with seven months of backlog, the analyst tells investors in a research note. Wolfe believes Bruker’s growth and margin trajectory in 2026 will drive valuation upside.